Cellectis S.A. appointed Mr. Axel-Sven Malkomes & Dr. Donald A Bergstrom, M.D., Ph.D. as Directors of Cellectis' Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 EUR | +1.06% | -5.16% | -13.53% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.53% | 181M | |
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |
- Stock Market
- Equities
- ALCLS Stock
- News Cellectis S.A.
- Cellectis S.A. Announces Executive Changes